Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2890843 | 0.95 | CYP1A2 (0.39) | CYP1A2TSHRPOLBABCB1CYP2C19 | |
| SCHEMBL10435405 | 0.80 | POLB (0.39) | CYP1A2TSHRPOLBCYP2C19 | |
| SCHEMBL11793132 | 0.78 | CYP1A2 (0.38) | CYP1A2TSHRPOLBCYP2D6 | |
| SCHEMBL9709460 | 0.78 | CYP1A2 (0.43) | CYP1A2TSHRPOLBCYP2C19IDO1 | |
| SCHEMBL28152768 | 0.76 | KMT2A (0.39) | — | |
| SCHEMBL15463430 | 0.76 | CYP1A2 (0.38) | CYP1A2TSHRPOLBCYP2C19CYP3A4 | |
| SCHEMBL653721 | 0.76 | POLB (0.38) | CYP1A2TSHRPOLBCYP2C19 | |
| SCHEMBL15972146 | 0.76 | POLB (0.38) | CYP1A2TSHRPOLBABCB1CYP2C19 | |
| SCHEMBL755810 | 0.74 | KMT2A (0.45) | CYP1A2TSHR | |
| SCHEMBL9015851 | 0.73 | TSHR (0.42) | CYP1A2TSHRCYP2C19CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5278148-A | Hypotensive agents | HOFFMANN-LA ROCHE INC. (US) | 1994-01-11 | — | — | US | disclosed |